Next Article in Journal
The CD73/Ado System—A New Player in RT Induced Adverse Late Effects
Next Article in Special Issue
Deregulated Lysophosphatidic Acid Metabolism and Signaling in Liver Cancer
Previous Article in Journal
FOXC1 Regulation of miR-31-5p Confers Oxaliplatin Resistance by Targeting LATS2 in Colorectal Cancer
Previous Article in Special Issue
Targeting Lysophosphatidic Acid in Cancer: The Issues in Moving from Bench to Bedside
Open AccessReview

Article Versions Notes

Cancers 2019, 11(10), 1577; https://doi.org/10.3390/cancers11101577
Action Date Notes Link
article xml file uploaded 16 October 2019 13:54 CEST Update https://www.mdpi.com/2072-6694/11/10/1577/xml
article xml uploaded. 16 October 2019 13:54 CEST Update https://www.mdpi.com/2072-6694/11/10/1577/xml
article pdf uploaded. 16 October 2019 13:54 CEST Updated version of record https://www.mdpi.com/2072-6694/11/10/1577/pdf
article html file updated 16 October 2019 13:56 CEST Update https://www.mdpi.com/2072-6694/11/10/1577/html
article html file updated 30 October 2019 21:05 CET Update https://www.mdpi.com/2072-6694/11/10/1577/html
article html file updated 14 February 2020 01:26 CET Update https://www.mdpi.com/2072-6694/11/10/1577/html
Back to TopTop